Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3744 QuetiapineTarget: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptorSummary: Dopamine receptor antagonist
-
A3874 Tiotropium BromideTarget: AChRSummary: MAChR M antagonist
-
B1620 Tolterodine tartrateTarget: AChRSummary: Competitive muscarinic receptor antagonist
-
B1616 Trospium chlorideTarget: AChRSummary: Antimuscarinic agent
-
B1612 Pancuronium dibromideTarget: AChRSummary: AChR antagonist
-
A5220 Vecuronium BromideTarget: AChRSummary: Nonpolarizing neuromuscular relaxant
-
C3869 BQCATarget: AChRSummary: positive allosteric modulator of the M1 muscarinic acetylcholine receptor (mAChR)